4.5 Review

Preserving human cells for regenerative, reproductive, and transfusion medicine

Journal

BIOTECHNOLOGY JOURNAL
Volume 9, Issue 7, Pages 895-903

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/biot.201300074

Keywords

Cryopreservation; Regenerative medicine; Reproductive medicine; Transfusion medicine; Vitrification

Funding

  1. NIH [R21-HL095960, R01-EB015776]

Ask authors/readers for more resources

Cell cryopreservation maintains cellular life at sub-zero temperatures by slowing down biochemical processes. Various cell types are routinely cryopreserved in modern reproductive, regenerative, and transfusion medicine. Current cell cryopreservation methods involve freezing (slow/rapid) or vitrifying cells in the presence of a cryoprotective agent (CPA). Although these methods are clinically utilized, cryo-injury due to ice crystals, osmotic shock, and CPA toxicity cause loss of cell viability and function. Recent approaches using minimum volume vitrification provide alternatives to the conventional cryopreservation methods. Minimum volume vitrification provides ultra-high cooling and rewarming rates that enable preserving cells without ice crystal formation. Herein, we review recent advances in cell cryopreservation technology and provide examples of techniques that are utilized in oocyte, stem cell, and red blood cell cryopreservation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available